1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trial Required) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH. This notice of funding opportunity invites applications to examine the efficacy and clinical effectiveness of multimodality digital health technology approaches to the management of type 2 diabetes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NIH Websites Are Changing A **. gov** website belongs to an official government organization in the United States.
Research & FundingExpand Research & Funding Research Programs & Contacts Research Training & Career Development Funded Grants & Grant History Technology Advancement & Transfer Health InformationExpand Health Information La información de la salud en español Diabetes Discoveries & Practice Blog Community Health & Outreach Budget & Legislative Information Advisory & Coordinating Committees 4.
The Application of Digital Health Technology to the Management of Type 2 Diabetes View Meetings & Workshops # The Application of Digital Health Technology to the Management of Type 2 Diabetes Sept. 5 - 6, 2024LocationContacts Registration ended Sept.
4, 2024 This workshop explores the application of currently available digital health technology to the management of type 2 diabetes, including continuous glucose monitoring, activity and sleep monitoring, mHealth applications and telemedicine. Both benefits and current barriers to the application of digital health to diabetes management will be fully explored.
* Provide an overview of current digital health technology (DHT) available for optimizing the management of type 2 diabetes mellitus * Review continuous glucose monitoring (CGM)-derived digital biomarkers and the use of CGM as a behavior modification tool * Examine current mHealth applications for monitoring activity, sleep, weight, ecological momentary assessment, and dietary intake * Explore patient and provider perspectives on the use of DHT to manage diabetes * Discuss the use of telemedicine to provide synchronous and asynchronous care in patients with diabetes * To understand current federal agency initiatives and perspectives on the application of DHT to diabetes management * Explore digital inclusivity as a pre-requisite to the widespread application of DHT to type 2 diabetes management * Examine the sustainability of DHT applications in type 2 diabetes management ## Thursday, September 5, 2024 8:30 a.
m. – 8:35 a. m.
**Welcome and Opening Remarks** Dr. William Cefalu, Director, Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH) Dr. Griffin P. Rodgers, Director, NIDDK, NIH 8:35 a. m.
– 8:45 a. m. **Overview of Workshop** Dr. Henry Burch, NIDDK, NIH **Introduction of Chairs** Dr. David Kerr, Sutter Health Dr. Anne Peters, University of Southern California Dr. Michael Snyder, Stanford University School of Medicine **Session I: Setting the Stage: Digital Health Technology -Type 2 Diabetes (DHT-T2D) 2024: Plenary Talk** Moderator(s): Dr. Henry Burch, NIDDK, NIH 8:45 a.
m. – 9:15 a. m.
**The Big Picture: Digital Health Technology for Chronic Disease Management** Dr. Geoffrey Ginsburg, All of Us Research Program, NIH 9:15 a. m. – 9:25 a.
m. **Digital Stretch Break** **Session II: Continuous Glucose Monitoring in Persons with T2 Diabetes** Moderator(s): Dr. Richard Bergenstal, International Diabetes Center Dr. Guillermo Arreaza-Rubin, NIDDK, NIH 9:25 a. m.
– 9:45 a. m. **Overview of Continuous Glucose Monitor (CGM) Devices and Methodology** Dr. Anders Carlson, International Diabetes Center 9:45 a.
m. – 10:05 a. m.
**Update on CGM Studies in T2D** Dr. Grazia Aleppo, Northwestern University 10:05 a. m. – 10:25 a.
m. **New Glycemia Indices – Going Beyond A1c** Dr. Richard Bergenstal, International Diabetes Center 10:25 a. m.
– 10:45 a. m. **Integration of CGM into Clinic Workflow** Dr. David Maahs, Stanford University 10:45 a.
m. – 11:15 a. m.
**Moderated Discussion**11:15 a. m. – 11:30 a.
m. **Break** **Session III: Wearable Devices and Mobile Health Applications** Moderator(s): Dr. Michael Snyder, Stanford University School of Medicine Dr. Henry Burch, NIDDK, NIH 11:30 a. m.
– 11:50 a. m. **Activity Monitoring in T2D – Is it Effective?
** Dr. Michael Riddell, University of York 11:50 a. m. – 12:10 p.
m. **Mobile Applications for Assessing Dietary Intake** Dr. Anne-Julie Tessier, Harvard University 12:10 p. m.
– 12:30 p. m. **Digital Sleep Tracking in Diabetes** Dr. Michael Snyder, Stanford University 12:30 p.
m. – 12:50 p. m.
**Wearable-Derived Digital Biomarkers of Prediabetes and Diabetes** Dr. Jessilyn Dunn, Duke University 12:50 p. m. – 1:50 p.
m. **Working Lunch and Moderated Discussion**1:50 p. m.
– 2:00 p. m. **Stretch Break** **Session IV: Bidirectional Communication – Patient and Provider** Moderator(s): Dr. Anne Peters, University of Southern California Dr. David Kerr, Sutter Health Dr. Shavon Artis Dickerson, NIDDK, NIH 2:00 p.
m. – 2:20 p. m.
**Use of Remote CGM Monitoring for People with Type 2 Diabetes Living in Under-Resourced Settings** Dr. Anne Peters, University of Southern California 2:20 p. m. – 2:40 p.
m. **Technology Access as a Social Determinant of Health** Dr. David Kerr, Sutter Health 2:40 p. m.
– 3:00 p. m. **Digital Navigation: Assessing and Addressing Digital Literacy Barriers** Dr. Lyndsay Nelson, Vanderbilt University 3:00 p.
m. – 3:20 p. m.
**Primary Care Perspective on Patient Engagement with DHT** Dr. Thomas Grace, Blanchard Valley Health System 3:20 p. m. – 4:00 p.
m. **Moderated Discussion**4:00 p. m.
**Meeting Adjournment** ## Friday, September 6, 2024 **Session V: Sustaining Patient Engagement in Digital Health Interventions** Moderator(s): Dr. Maureen Monaghan-Center, NIDDK, NIH Dr. Theresa Woo, NIDDK, NIH Dr. Anne Peters, University of Southern California 8:50 a. m. – 9:10 a.
m. **Digitally Delivered Behavioral Economics in Diabetes Management** Dr. Jeffrey Kullgren, University of Michigan 9:10 a. m.
– 9:30 a. m. **Peer Networking in Digital Diabetes Management** Dr. Michelle Litchman, University of Utah 9:30 a.
m. – 9:50 a. m.
**Digital Gaming Applications for Health Management** Dr. Veronica Brady, University of Texas 9:50 a. m. – 10:20 a.
m. **Moderated Discussion**10:20 a. m.
– 10:35 a. m. **Break** **Session VI: Federal Agency Perspective on Implementation of DHT for T2D** Moderator(s): Moderator(s): Dr. William Cefalu, Chair, DEM and Chair, DMICC, NIDDK, NIH 10:35 a.
m. – 10:55 a. m.
**FDA Digital Health Center of Excellence Overview** Dr. Matthew Diamond, Chief Medical Officer, Digital Health Center of Excellence 10:55 a. m. – 11:15 a.
m. **Veterans Affairs Initiatives on DHT in T2D** Dr. Meredith Josephs, Director, Connected Health, Veterans Administration 11:15 a. m.
– 11:35 a. m. **Centers for Disease Control and Prevention’s (CDC) Global Digital Health Strategy** Dr. Christopher Holliday, Director, Division of Diabetes Translation 11:35 a.
m. – 12:05 p. m.
**Panel Discussion (FDA, VA, CDC)**12:05 p. m. – 12:35 p.
m. **Lunch Break (Box Lunches)** **Session VII: Multimodality Approaches to Diabetes Management, Data Aggregation, and EHR Integration** Moderator(s): Dr. David Klonoff, University of California, San Francisco Dr. Xujing Wang, NIDDK, NIH 12:35 p. m.
– 12:55 p. m. **Welldoc/BlueStar** Dr. Anand Iyer, Chief Artificial Intelligence Officer 12:55 p.
m. – 1:15 p. m.
**Virta Health** Dr. Rebecca Adams, Verily Health Director of Research 1:15 p. m. – 1:35 p.
m. **Verily/Onduo** Dr. Eric Huang, Verily Health 1:35 p. m.
– 1:55 p. m. **Data Aggregation and EHR Integration** Dr. Juan Espinoza, Lurie Children’s Hospital Center 1:55 p.
m. – 2:25 p. m.
**Moderated Discussion**2:25 p. m. – 2:40 p.
m. **Break** **Session VIII: Summary of Research Gaps Identified During Workshop and Closing Remarks** Moderator: Moderator: Dr. Henry Burch, NIDDK, NIH 2:40 p. m.
– 3:00 p. m. **Summary of Identified Research Gaps** Panel of Section Moderators 3:00 p.
m. – 3:45 p. m.
**Closing Remarks** Dr. David Kerr, Sutter Health Dr. Anne Peters, University of Southern California Dr. Michael Snyder, Stanford University Dr. Henry Burch, NIDDK, NIH Dr. William Cefalu, NIDDK, NIH 3:45 p. m. **Meeting Adjournment** Registration ended Sept.
4, 2024 Building 31, 6C, Rooms A&B This is a hybrid workshop. Virtual participation is available. For those attending via webinar, the link will be distributed via email prior to the date of the event.
Email: henry. burch@nih. gov Email: mdennis@scgcorp.
com The Scientific Consulting Group, Inc. PrintFacebookXEmailMore OptionsWhatsAppLinkedInRedditPinterestCopy Link NIH… Turning Discovery Into Health ® * Freedom of Information Act * U.S. Department of Health and Human Services * National Institutes of Health
According to the current listing, eligibility includes: Eligible applicants include Public, state controlled, and private institutions of higher education; Federally recognized Native American tribal governments; County, Special district, Public and Indian housing authoritie…. Confirm the full requirements in the official notice before applying.
Applications for Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trial Required) are due October 6, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trial Required) is funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article